The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
0942-0940
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study ; day:13 ; month:10 ; year:2021 ; pages:1-13
Acta neurochirurgica ; (13.10.2021), 1-13
- Creator
-
Ita, Michael Itak
Wang, Jiang Huai
Toulouse, André
Lim, Chris
Fanning, Noel
O’Sullivan, Michael
Nolan, Yvonne
Kaar, George Finbarr
Redmond, Henry Paul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00701-021-05014-8
- URN
-
urn:nbn:de:101:1-2021122719301491208176
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ita, Michael Itak
- Wang, Jiang Huai
- Toulouse, André
- Lim, Chris
- Fanning, Noel
- O’Sullivan, Michael
- Nolan, Yvonne
- Kaar, George Finbarr
- Redmond, Henry Paul
- SpringerLink (Online service)
Other Objects (12)
Circulating cell-free DNA and its clinical utility in cancer
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
New approaches for detecting cancer with circulating cell-free DNA
Clinical relevance of circulating cell-free microRNAs in ovarian cancer
Circadian rhythm and circulating cell-free DNA release on healthy subjects
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Messenger
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
Circulating cell-free DNA and its clinical utility in cancer
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
New approaches for detecting cancer with circulating cell-free DNA
Clinical relevance of circulating cell-free microRNAs in ovarian cancer
Circadian rhythm and circulating cell-free DNA release on healthy subjects
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Messenger
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
Circulating cell-free DNA and its clinical utility in cancer
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
New approaches for detecting cancer with circulating cell-free DNA
Clinical relevance of circulating cell-free microRNAs in ovarian cancer
Circadian rhythm and circulating cell-free DNA release on healthy subjects
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Messenger